Abstract. Many integrins recognize short RGD-containing amino acid sequences and such peptide sequences can be identified from phage libraries by panning with an integrin. Here, in a reverse strategy, we have used such libraries to isolate minimal receptor sequences that bind to fibronectin and RGD-containing fibronectin fragments in affinity panning. A predominant cyclic motif, *CWDDC/LWLC *, was obtained (the asterisks denote a potential disulfide bond). Studies using the purified phage and the corresponding synthetic cyclic peptides showed that *CWDDGWLC*-expressing phage binds specifically to fibronectin and to fibronectin fragments containing the RGD sequence. The binding did not require divalent cations and was inhibited by both RGD and *CWDDGWLC*-containing synthetic peptides. Conversely, RGD-expressing phage attached specifically to immobilized *CWDDGWLC*-peptide and the binding could be blocked by the respective synthetic peptides in solution. Moreover, fibronectin bound to a *CWDDGWLC*-peptide affinity column, and could be eluted with an RGD-containing peptide. The *CWDDGWLC*-peptide inhibited RGD-dependent cell attachment to fibronectin and vitronectin, but not to collagen. A region of the [3 subunit of RGD-binding integrins that has been previously demonstrated to be involved in ligand binding includes a polypeptide stretch, KDDLW (in [33) similar to WDDC/LWL. Synthetic peptides corresponding to this region in [33 were found to bind RGD-displaying phage and conversion of its two aspartic residues into alanines greatly reduced the RGD binding. Polyclonal antibodies raised against the *CWDDGWLC*-peptide recognized [31 and [~3 in immunoblots. These data indicate that the *CWDDGWLC*-peptide is a functional mimic of ligand binding sites of RGD-directed integrins, and that the structurally similar site in the integrin t3 subunit is a binding site for RGD.
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I
NTEGRINS are heterodimeric glycoproteins formed by the association of an tx and a 13 subunit; they mediate cell-matrix and cell-cell interactions that are important in biological events such as cell differentiation, malignant transformation, immune recognition, and blood coagulation (13, 16, 19, 38) . Some of the integrin effects in these phenomena are the consequence of physical adhesion, others are mediated by signal transduction through integrin cytoplasmic domains (17, 20, 30, 46) .
An important integrin binding site is the tripeptide RGD, present in a variety of integrin ligands. In fibronectin, it is located in the tenth type III repeat (III10) 1 (34, 35) , the structure of which has been elucidated by NMR (26) and crystallography (11) . Studies with fibronectin fragments and phage display libraries have suggested that other sites in this region of fibronectin are also needed for full integrin-binding activity (4, 23, 31) .
Contact regions for the RGD sequence have been identified in the integrin subunits (14) . Affinity cross-linking of RGD peptides and site-directed mutagenesis localize a ligand-binding site in the alIb[33 integrin at amino acid residues 109-172 of the [~ subunit (2, 3, 6, 8, 33) . Studies with the av133 integrin place an RGD-binding site at amino acids 61-203 (41) , and a similar cross-linking region, amino acids 120-140 in the [31 subunit, has also been found to be involved in ligand binding (43) . In each case, the RGD-binding site is near or at a site that binds divalent cations. The c~ subunit also contains one or more ligandbinding sites; as with the 13 subunits, these sites localize to the divalent cation binding sequences (5, 7, 12, 25, 27) .
Our laboratory has used random peptide libraries displayed on phage (40) to study the structural requirements in the RGD-type peptide ligands for their binding to integrins. Searches of such libraries have confirmed the central role of the RGD sequence in ligand binding by several integrins and have also revealed auxiliary binding sites in the ligands (15, 21-24, 29, 42) . Here we have used the reverse strategy in an attempt to elucidate the sequences in integrins that are important for ligand binding. We report here the identification and characterization of an RGD-binding sequence, *CWDDGWLC*, from a random phage display library. This peptide is similar to key residues in the integrin ligand binding site and thus appears to be a structural mimic of an RGD contact point in integrins.
Materials and Methods

Materials
Human plasma fibronectin was from the Finnish Red Cross (Helsinki, Finland). A 110-kD fragment of fibronectin was prepared as described previously (34) . Recombinant fibronectin fragments containing type III repeats 8 and 9, 9 and 10, 10 and 11, 10 alone, and 8 through 11 were produced as described (10), using GST (Pharmacia, Uppsala, Sweden) (for the 8 through 11 fragment) and His-Tag (Qiagen, Chatsworth, CA) (for the other four fragments) fusion protein systems. A fragment encompassing the alternatively spliced cell attachment domain of fibronectin (amino acids 1860-2140) was also produced using the His-Tag system. Vitronectin was purified from human plasma as described (47 
Panning of Phage
Aliquots of the libraries were screened with fibronectin fragments coated on microtiter wells. Panning was performed on each fragment individually. In the first and second panning the coating concentration of protein was 5 ~g/well. To increase the stringency of the panning, the wells were coated with decreasing concentrations of protein (1 and 0.1 p,g/weli). Phage were selected for further amplification from the well with the lowest protein concentration that showed phage binding over background. In the fourth panning, the concentration was 10 ng/well. To recover the bound phage, the wells were eluted with 1 mM solution of GRGDSP or *CELRGDGWC* peptides, 2 mM EDTA, or were directly incubated with 50 Ixl of bacteria. Phage were sequenced from randomly selected clones as described (22) .
Phage Attachment Assay
Binding of individual cloned phage to insolubilized fibronectin and fibronectin fragments was studied in microtiter assays (22, 23) . The coating concentration for the proteins was 10 p~g/ml. Coating with peptides was carried out at 10-t00 ixg/ml overnight with or without 1 mM divalent cations. Phage binding was determined by growing K91kan bacteria in the presence of the selection marker tetracyclin. The absorbance at 600 nm was read after 16--24 h of incubation at room temperature (22) . Alternatively, the phage binding was also quantified by using sheep anti-M13 polycIonal antibodies (1 vg/ml; Pharmacia). Readings at 450 nm were analyzed after incubation with alkaline phosphatase conjugated anti-sheep IgG (1:10,000; Sigma).
Affinity Chromatography
Peptides were coupled to Sepharose-CH (Pharmacia) according to the manufacturer's instructions. Fibronectin and fibronectin fragments at 2 mg/ml in TBS were applied onto the *CWDDGWLC*-Sepharose or to a control peptide column. After extensive washing with TBS, bound material was elnted with GRGDSP and GRGESP peptides (1 mM) or glycine (0.1 M) containing NaCl (0.1 M, pH = 3.0). Samples were concentrated when necessary and analyzed in SDS-PAGE pre-cast gradient mini gels. Proteins were visualized by Coomassie blue staining.
Cell Attachment Assays
An osteosarcoma cell line, MG-63, which attaches to fibronectin, vitronectin, and collagens through its complement of several integrins (37) , was used in cell attachment assays to examine peptide inhibition of integrin function. Microtiter wells were coated with fibronectin, vitronectin or type IV collagen at concentrations that resulted in 60% of maximal attachment (~5 i~g/ml). Free binding sites on plastic were blocked with BSA. Approximately 1 × 10 s cells per well were allowed to attach for 30 min in the presence or absence of competing peptides and the bound cells were quantitated by staining with crystal violet (28) .
Immunization and Immunoblot Analysis
RBF-Dnj mice (Jackson Laboratories, Bar Harbor, ME) were immunized with the *CWDDGWLC* peptide coupled to sheep red blood cells (Sigma) according to the manufacturer's instructions.
Purified cdIb133 (2 ixg/lane) and MG-63 cell extracts (20 ~1 from a vol/ vol detergent/cell pellet solution) were separated on 4-12% gradient SDS-PAGE and transferred to Immobilon-P membranes. After blocking of non-specific sites, filters were probed with anti-*CWDDGWLC* (1:200) and anti-133 cytoplasmic domain polyclonal serum (1:1,000). Normal mouse and rabbit sera were used as negative controls. Reactivity of antibodies was detected with anti-mouse or rabbit IgG, and chemiluminescence (ECL; Amersham).
Results
Isolation of Phage Capable of Binding to Fibronectin Fragments
To identify peptide motifs that interact with the RGDcontaining 10th type III domain of fibronectin (III10), recombinant fibronectin fragments were used to select clones from a mixture of peptide libraries by successive rounds of affinity panning and elution with RGD-containing peptide. Decreasing protein coating concentration in the second and third rounds, and the use of excess of phage to introduce binding competition, allowed for selection of specific, high-affinity phage 50-to 150-fold enrichment was achieved on IIIi0-bearing fragments in the third round of panning (Fig. 1) . The fragment containing the 10 lh and 11 th type III repeats of fibronectin was the most efficient binder of specific phage. Enrichment was also seen on the recombinant fibronectin fragment bearing the III10 domain alone, but not on the fragment from the alternatively spliced fibronectin domain containing the CS-1 binding site for a4f31 integrin (18) (results not shown). Binding of phage to fragment III8,9 was also low, indicating that the IIIt0 domain was important for the enrichment of RGDeluted phage. GST and BSA were used as controls for non-specific attachment and showed negligible phage binding. Enrichment of specific phage was also seen with the RGD-coating fragments when the phage were eluted with EDTA or collected by direct infection of bacteria added to the washed wells (see below).
Phage Selected by RGD-containing Fibronectin Fragments Display the *CWDD6/L WLC * Peptide Motif
Sequences of the insert in the phage eluted with RGD peptides, EDTA, or recovered by direct incubation of bacteria showed that ~80-85% of the clones displayed the motif WDDGWL (Table I) . Some of the other motifs found were similar to the WDDGWL sequence; the glycine residue was frequently replaced by leucine. 
Binding of WDDGWL Phage to the III10 Domain Is Blocked with Synthetic Peptides
The specificity of the WDDGWL-phage binding to fibronectin and fibronectin fragments was tested in a microtiter assay. The binding was dependent on the presence of the III10 domain (Fig. 2 a) . Binding to III8,9, to control proteins (BSA and GST) and also to the fragment encompassing the alternatively spliced cell attachment domain of fibronectin (not shown) was minimal. An unrelated phage (10) LVWLLVQFY (2) WDDGLM (7) TFGGGIGRV (l) WDDGWM (4) TLRFQRS (1) WDDGWL (45) SWDDGWL (6) PDDLWWL (3) DGWLGF (2) QRIVLGFT (1) DYWLGF (1) FVLWLV (1) GNRLR (1) Peptide sequences displayed by phage isolated by different elution strategies. The number of phage displaying the same amino acid motif is indicated in parenthesis.
displaying the peptide R D P R A Q D L showed no binding to fibronectin or any of its fragments. Two cyclic peptides, *CWDDGWLC* and A*CRGDG-WMC*G, were synthesized and tested for their ability to inhibit phage binding to the III10al fragment. Both peptides, but not an irrelevant cyclic one, inhibited WDD-GWL-phage binding in a dose-dependent manner (Fig. 2  b) . E D T A did not inhibit the binding of W D D G W Lphage (not shown), although we had detected WDD-GWL-phage in the E D T A eluates after affinity panning. The recovery of the W D D G W L -p h a g e with E D T A (Table I) may have represented non-specific release of the bound phage rather than specific elution, because less phage was eluted than with the R G D peptide.
Phage Attachment to Immobilized Peptides
The binding of W D D G W L and RGD-displaying phage to R G D and WDDGWL-containing peptides was analysed in phage attachment assays using *CWDDGWLC*, A*CRG-DGWMC*G, and an irrelevant cyclic peptide as substrates. We were able to show that W D D G W L -p h a g e can bind to the RGD-containing peptide. Conversely, R G Dphage can bind to the *CWDDGWLC*-containing peptide (Fig. 3 a) . The R G D phage also showed slight, but consistent, binding to the peptide displaying the same RGD motif, RGDGW. Addition of either the *CWDDG-WLC* or A*CRGDGWMC*G peptide in solution blocked the W D D G W L -p h a g e binding (Fig. 3 b) , whereas an unrelated peptide had no effect (not shown). The binding of RGD-phage was also inhibited by both peptides, and was unaffected by the control peptide (Fig. 3 c) or by E D T A (not shown).
Fibronectin Binds to *CWDDGWLC* Sepharose
Affinity chromatography showed that fibronectin bound to *CWDDGWLC*-Sepharose, and was eluted with the G R G D S P peptide but not with the GRGESP peptide (Fig. 4 a) . Fibronectin was not retained in a control unrelated peptide column (not shown). Fibronectin fragments lacking the III10 domain and unrelated proteins (BSA and type IV collagen) were not retained in the *CWDDG-WLC*-Sepharose column. The difference between the binding of the IIIqA 0 ( R G D + ) and III8, 9 ( R G D -) fragments to the *CWDDGWLC* column is shown in Fig. 4 b.
*CWDDGWLC* Inhibits RGD-dependent Cell Adhesion
The *CWDDGWLC* peptide inhibited cell adhesion when either fibronectin or vitronectin were used as substrates, but not on collagen (Fig. 5 ). An unrelated cyclic peptide had no effect on any of the substrates. *CWDDGWLC* was slightly less effective than the standard R G D peptide, G R G D S P (not shown). Fig. 6 , R G D -p h a g e bound to the 113(109-133) peptide. The binding required the presence of divalent cations, either while the peptide was coated onto plastic or during the phage binding (Fig. 6 a) . (Fig. 6 b) . The two peptides were equally effective; in titration experiments 50% inhibition was achieved at about 1 I~M concentration of the peptides (not shown). However, E D T A did not block phage binding when peptides were allowed to coat in the presence of cations.
*CWDD~/L WLC * Resembles a Peptide from f13 Integrin Subunit
V D I Y Y L M D L S Y S M K D D L W S I Q N ) binds to an R G D peptide (9). As shown in
The binding of the R G D -p h a g e binding was blocked by the addition of soluble * C W D D G W L C * or G R G D S P peptides
To 
Antibodies against *CWDDGWLC* Peptide Recognize ~3 and ~31 in Immunoblots
Further evidence for the structural similarity between * C W D D G W L C * and [3 subunits was obtained with antibodies raised against * C W D D G W L C * peptide. When purified c~IIb133 was probed in immunoblots with anti-*CWD-DGWLC*, a band was detected that had the expected molecular size of 113 and aligned with the band detected by anti-113 cytoplasmic domain antiserum (Fig. 7 a) . Reactivity of the anti-*CWDDGWLC* serum could be abrogated by preincubation of the serum with either the * W D D G -WLC* or the [33 (109-133) peptide (Fig. 7 a, lanes C and  D, respectively) . The anti-*CWDDGWLC* serum also reacted with bands that co-migrated with 131 and 113 subunits in MG-63 total cell extracts (Fig. 7 b, 
Discussion
We have used phage peptide libraries to identify a cyclic peptide motif, represented by the sequence WDDGWL, that binds to the RGD-containing domain of fibronectin. This motif seems to be a structural mimic of an RGDbinding site in integrin ~3 subunits. The W D D G W L sequence and its variations (flanked by cysteine residues engineered into the libraries) was by far the most frequently isolated sequence on the RGD-containing fibronectin fragments. The sequences that were not related to the W D D G W L motif were hydrophobic and/or seen only once. The binding of these phage is likely to have been non-specific; they were lost in the subsequent high affinity screening steps and were not seen at all when specific elution with an R G D peptide was used.
The binding of the W D D G W L phage to the RGD-containing fragments was specific because only background binding was seen when fragments lacking the RGDcontaining III10 domain, or control proteins, were used. Moreover, panning performed using the function-blocking anti-cxlIb[33 monoclonal antibodies, PAC-1, OPG2, and LJ-CP3, which each contain an RYD sequence as an R G D mimic (1, 44, 45) Table If ) may explain the differences in the ability of integrins containing different [3 subunits to bind to RGDcontaining ligands. Because several contact areas may be necessary for ligand binding, regions in the c~ chain are also likely to affect integrin specificity. In the [3 subunit binding site, the tryptophan residue, only present in [33, may be important because it was nearly invariant in the phage that bound avidly to the R G D ligands.
Phage-peptide binding studies revealed a preliminary result that deserves comment. As shown in Fig. 3 a, there was some binding by phage displaying the sequence RG-D G W to an immobilized peptide containing this same motif. As the R G D G W sequence has some similarity with WDDGWL, it may be that the R G D G W motif mimics the integrin while also being self-complementary. It has been proposed that receptor-ligand pairs arise in evolution from sequences that occur frequently in proteins, because the probability for a newly emergent receptor (or ligand) would find a useful ligand (or receptor) is greatest when the reciprocal binding sequence is common (32); Our results suggest an alternative scenario for the emergence of the integrin-RGD recognition system, i.e., self complementarity.
The fact that the *CWDDGWLC* peptide binds to both fibronectin and vitronectin (and apparently also to antibodies that mimic RGD-containing ligands) suggests that such peptide might be useful in the isolation of unknown integrin ligands. Conversely, antibodies made against the peptide may be used to identify new integrin [3 subunits .
The W D D G W L motif places the R G D binding site to the same region of the ~ subunit that was identified in earlier studies (Table II) (2, 3, 6, 8) region. Mutagenesis of residues in the cation binding motif eliminates divalent cation binding or reduces ligand binding by the whole integrin. However, one such mutation of Asp 119 to tyrosine (see Table II ), while rendering the whole integrin inactive, fails to affect R G D binding by the binding region peptide (9) . Our results with the [33 subunit peptide are similar to those of D'Souza et. al. (9), but we found that the presence of divalent cations is required for R G D binding either when the peptide was coated onto plastic, or during the binding assay. We were using a cyclic R G D peptide displayed on phage, whereas D'Souza et al. used a synthetic RGD peptide, and the divalent cation requirements for the binding of different ligands to the same binding structure on the integrin may vary (25) . As the WDDGW motif lacks the divalent cation binding sequence, which is at the NH2 terminus of the peptide (9), we suggest the following model for the RGD binding: The actual RGD binding site is predominantly located in the W D D G W similarity region, and in the intact integrin the activity of this site depends on the binding of a cation to the adjoining divalent cation binding site; the cyclic WDDGWL peptide may assume the RGD-binding conformation without divalent cation binding because the disulfide bond stabilizes the RGD-binding conformation. The binding of an RGD ligand may in turn affect the divalent cation binding site, as it causes extrusion of the cation from the integrin (9) . One earlier result would not appear to agree with our hypothesis that the DDLW sequence in the integrin could be important in ligand binding; Bajt et al. (3) found that mutating the aspartic acid residues in this sequence to alanines did not appreciably affect the binding of the alIb[33 integrin to fibrinogen. A possible explanation of this result is that ~IIb[33 is known to recognize the "V chain KQGDV sequence in fibrinogen, and unlike RGD peptides which bind to the 13 subunit, this sequence binds mostly to the The amino acid sequences of integrin 13 subunits are shown using the single-letter code. Residues D119, D126, and D127 within the 133 subunit are underlined.
subunit as measured by affinity labeling (36, 39) . The binding of the mutant alIb[33 integrin to the RGD-mimic OPG2 antibody was lost and, as the WDDGWL similarity region appears to be the RGD binding site, it may be that changes in this region within intact integrins would affect only the binding of RGD ligands.
